Navin Flourine gets its highest share price target from UBS on strong CDMO, chemicals outlook

Shares of Navin Fluorine International opened up nearly 2% on Monday, December 1, after global brokerage firm UBS raised its target price on the counter, helping the stock extend its gains for a second straight session.

UBS has reiterated its 'Buy' rating and increased its target price to ₹7,000, the highest price target on the Street.

The brokerage said that Navin Fluorine delivered strong growth and margin performance in the first half, supported by firm refrigerant realisations and demand, continued momentum in its CDMO business, and a stable uptick in specialty chemicals.

UBS expects this momentum to sustain, citing improved visibility in the CDMO segment as the company readies to begin operations at its cGMP-4 Phase 1 unit, along with the possibility of repeat orders for a high-growth molecule in 2026.

It also sees robust growth in high-performance products and specialty chemicals, aided by better utilisation and upcoming capacity additions.

With a stronger balance sheet following its recent QIP, UBS believes Navin Fluorine is well placed to continue its capex-led expansion. The stock has risen about 75% year-to-date, and UBS said the market still does not fully reflect the company's CDMO growth potential or margin expansion opportunity.

Of the 28 analysts tracking the stock, 20 have a 'Buy' rating, three recommend 'Hold', while five have 'Sell' calls.

Navin Fluorine shares were trading 0.74% higher at ₹5,778 on Monday. The stock is up 76% so far in 2025.